Literature DB >> 35482084

The association between the severity of periodontitis and osteonecrosis of the jaw in patients with different cancer locations: a nationwide population-based study.

Yi-Fang Huang1,2,3, Kuan-Chou Lin2,4, Shih-Ping Liu5,6,7, Chung-Ta Chang2,8,9, Chih-Hsin Muo10, Po-Jen Chang2, Chun-Hao Tsai11,12, Ching-Zong Wu13,14,15.   

Abstract

OBJECTIVES: To determine the relation between the severity of periodontitis and osteonecrosis of the jaw (ONJ) occurrence among different cancer locations and estimate the effect of dental care on ONJ prevention in cancer patients.
MATERIALS AND METHODS: This population-based cross-sectional study was conducted through the Longitudinal Health Insurance Database, Taiwan. Patients with malignancies were collected and subdivided into groups according to their different cancer locations, the severity of periodontitis, and dental care. Multivariable logistic regression analysis was performed to assess the associations between ONJ and ONJ-related factors.
RESULTS: A total of 8,234 ONJ patients and 32,912 control patients were investigated. Lip, oral cavity, and pharynx malignancies had the highest ONJ risk among all cancer locations (OR from 3.07 to 9.56, P < 0.01). There is a linear relationship between different severities of periodontitis and ONJ. Patients with radiotherapy and severe periodontitis had the highest ONJ risk (adjusted OR, 9.56; 95% CI, 5.34-17.1). Patients with good dental care had a lower ONJ risk.
CONCLUSIONS: The periodontal condition and cancer location showed a significant impact on the risk of developing ONJ after adjusting for bisphosphonate use. Good dental care could decrease the risk of ONJ in cancer patients. The severity of periodontitis might be a target to predict the potency of ONJ. CLINICAL RELEVANCE: Dentists must be vigilant about the increased risk of ONJ in cancer patients with periodontitis, especially in the head and neck cancer population. Good dental care is advised for cancer patients with severe periodontitis.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cancer location; Dental care; ONJ; Osteonecrosis of the jaw; Periodontitis; Population-based

Mesh:

Substances:

Year:  2022        PMID: 35482084     DOI: 10.1007/s00784-021-04175-1

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  32 in total

1.  Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.

Authors:  J Ignacio Aguirre; Mohammed P Akhter; Donald B Kimmel; Jennifer E Pingel; Alyssa Williams; Marda Jorgensen; Lakshmyya Kesavalu; Thomas J Wronski
Journal:  J Bone Miner Res       Date:  2012-10       Impact factor: 6.741

2.  Clinical comparison of patients with osteonecrosis of the jaws, with and without a history of bisphosphonates administration.

Authors:  M Kos; D Brusco; J Kuebler; W Engelke
Journal:  Int J Oral Maxillofac Surg       Date:  2010-11       Impact factor: 2.789

3.  Prevalence of periodontitis in adults in the United States: 2009 and 2010.

Authors:  P I Eke; B A Dye; L Wei; G O Thornton-Evans; R J Genco
Journal:  J Dent Res       Date:  2012-08-30       Impact factor: 6.116

4.  Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

Authors:  Robert E Marx; Yoh Sawatari; Michel Fortin; Vishtasb Broumand
Journal:  J Oral Maxillofac Surg       Date:  2005-11       Impact factor: 1.895

5.  Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphanates.

Authors:  M Pavkovic; G Petrushevska; R Jovanovic; O Karanfilski; L Cevreska; S Stankovic; A Stojanovic
Journal:  Prilozi       Date:  2010

6.  Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.

Authors:  Rebecca Anne Miksad; Kuan-Chi Lai; Thomas Benton Dodson; Sook-Bin Woo; Nathaniel Simon Treister; Omosalewa Akinyemi; Marian Bihrle; Guy Maytal; Meredith August; G Scott Gazelle; J Shannon Swan
Journal:  Oncologist       Date:  2011-01-06

7.  Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study.

Authors:  T Yamazaki; M Yamori; T Ishizaki; K Asai; K Goto; K Takahashi; T Nakayama; K Bessho
Journal:  Int J Oral Maxillofac Surg       Date:  2012-07-26       Impact factor: 2.789

Review 8.  Degenerative periodontal-diseases and oral osteonecrosis: the role of gene-environment interactions.

Authors:  D Baldi; A Izzotti; P Bonica; P Pera; A Pulliero
Journal:  Mutat Res       Date:  2008-11-14       Impact factor: 2.433

Review 9.  Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.

Authors:  Aliya A Khan; Archie Morrison; David A Hanley; Dieter Felsenberg; Laurie K McCauley; Felice O'Ryan; Ian R Reid; Salvatore L Ruggiero; Akira Taguchi; Sotirios Tetradis; Nelson B Watts; Maria Luisa Brandi; Edmund Peters; Teresa Guise; Richard Eastell; Angela M Cheung; Suzanne N Morin; Basel Masri; Cyrus Cooper; Sarah L Morgan; Barbara Obermayer-Pietsch; Bente L Langdahl; Rana Al Dabagh; K Shawn Davison; David L Kendler; George K Sándor; Robert G Josse; Mohit Bhandari; Mohamed El Rabbany; Dominique D Pierroz; Riad Sulimani; Deborah P Saunders; Jacques P Brown; Juliet Compston
Journal:  J Bone Miner Res       Date:  2015-01       Impact factor: 6.741

10.  Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw.

Authors:  Smruti Pushalkar; Xin Li; Zoya Kurago; Lalitha V Ramanathapuram; Satoko Matsumura; Kenneth E Fleisher; Robert Glickman; Wenbo Yan; Yihong Li; Deepak Saxena
Journal:  Int J Oral Sci       Date:  2014-08-08       Impact factor: 6.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.